Follow Us:
Fenspiride Exporter From India

Fenspiride

Xerava

Fenspiride is a respiratory medication historically used for the symptomatic treatment of inflammatory conditions of the respiratory tract, including cough associated with certain respiratory diseases. It was believed to exert anti-inflammatory effects that could help alleviate respiratory symptoms. However, Fenspiride’s marketing authorisations were revoked in the European Union in 2019 due to the risk of QT prolongation and potentially serious heart rhythm disturbances. Its current regulatory status and availability must be verified in the relevant country before any use, supply, or distribution.

  • Dosage Form: Oral Solution
  • Dosage Strength: 50 ML
  • Manufacturer: Tetraphase Pharmaceuticals, Inc.
  • CAS No.: 5053-08-7
  • Status: Yes

Applications of Fenspiride

Fenspiride was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:

check application is okay

Contraindication of Fenspiride

Contraindication

Availability of Fenspiride

Availability

Delivery of Fenspiride

Delivery

Frequently Asked Questions

The most frequently asked questions focus on import, export, documentations, and regulation for Fenspiride.

The Fenspiride Hydrochloride is a pharmaceutical active pharmaceutical ingredient (API) used in manufacturing of Fenspiride.

Green Stone Swiss Co., Ltd : Provides active pharmaceutical ingredients (APIs), customized production, and OEM/ODM services with research and technical cooperation across Europe, the USA, and India via Primeera Healthcare.

  • Therapeutic Goods Administration (TGA): Not Approved
  • US Food and Drug Administration (USFDA): Not Approved
  • European Medicines Agency (EMA): Not Approved
  • African Medicines Agency (AMA): Not Approved
  • National Medical Products Administration (NMPA): Not Approved
  • Central Drugs Standard Control Organization (CDSCO): Not Approved

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Fenspiride, subject to confirmation of its current regulatory status and eligibility for import into India.

Documentation Required for Fenspiride Import

The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.

Import Regulations and dcoumentation for Fenspiride

  • Import Documentation Assistance:
    Support with organising commercial invoices, packing lists, manufacturer details, product specifications, certificates of analysis, and other relevant documents required for regulatory review and customs processing.

  • Regulatory Coordination:
    Assistance with identifying applicable CDSCO requirements, import authorisations, and documentation procedures, subject to the product's regulatory status and the proposed import route.
  • Shipping and Customs Coordination:
    Coordination with relevant logistics providers and customs professionals to organise shipment documentation and facilitate clearance where legally permitted.
  • Compliance Verification:
    Preliminary review of available product and shipment documentation to identify potential regulatory gaps before procurement or dispatch. Import arrangements will proceed only after the applicable permissions and restrictions have been verified.

Customs Clearance and Compliance Handling of Fenspiride Import

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Fenspiride, subject to confirmation of its current regulatory status and eligibility for import into India.

Export Regulations and dcoumentation for Fenspiride

The export of Fenspiride from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.

Documentation Required for Fenspiride Emport

  • Export Documentation Assistance:
    Assistance with organising commercial invoices, packing lists, manufacturer details, Fenspiride specifications, certificates of analysis, and other supporting documents required for Fenspiride export and customs processing.
  • Regulatory Coordination:
    Support in identifying applicable country specific Fenspiride export requirements, relevant manufacturing and export authorisations, and destination-country registration or import approval requirements, subject to the Fenspiride regulatory status.
  • Shipping and Customs Coordination:
    Coordination with logistics providers, freight forwarders, and customs professionals to organise shipping documentation, export declarations, and customs clearance procedures where legally permitted.
  • Compliance Verification:
    Preliminary review of available Fenspiride documentation, labelling, Fenspiride manufacturing information, and destination-market requirements to identify potential regulatory gaps before dispatch. Export arrangements will proceed only after the applicable restrictions and authorisations have been verified.

Customs Clearance and Compliance Handling of Fenspiride Export

Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Fenspiride, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.

Product Export Support

If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Email Us

info@primeerahealthcare.com

Call Us

+(123) 456 789 00

Follow Us

Primeera Healthcare

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.